Vistagen advances PALISADE-4 trial with $61.8M in cash while refining placebo mitigation strategies
Platinum Analytics Cayman Limited Class A Ordinary Shares · Now $17.50
Outcome chart not yet available
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS